4 Thriving Investment Bank Behemoths to Buy With Attractive Valuation

Zacks rates the investment-bank industry in the top 16% of its industry rankings after 26.7% returns over the past year and 12.8% year-to-date, citing recovering underwriting and advisory activity, strong trading and AI-driven efficiency gains. It recommends JPMorgan, Goldman Sachs, Citigroup and Morgan Stanley, all ranked Buy or Strong Buy, with current-year expected earnings growth of 22.6%, 34.2%, 40.7% and 25.4%, respectively. The report highlights comparatively attractive valuations, particularly Citigroup at 12.29x forward P/E, 1.35x sales and 1.21x book value, alongside positive earnings-estimate revisions and a supportive capital-markets outlook.

Analysis

The investable distinction is not broad investment-bank beta but earnings durability after the capital-markets rebound normalizes. GS has the greatest operating leverage to advisory, underwriting and trading, making it the best vehicle for another 1-3 months of improving deal-announcement data—but also the most exposed if activity merely meets already-raised expectations. JPM offers the cleaner all-weather earnings mix; its premium is justified by deposit, card and commercial-banking optionality, although that makes it less likely to deliver a valuation-driven upside surprise.

C remains the highest-convexity turnaround: a sustained reduction in its cost base and evidence of capital return can close part of its material valuation discount over 6-18 months. The market will require realized expense execution and improved return on tangible common equity, rather than another target reset; this makes C more attractive than GS on medium-term risk/reward despite lower near-term estimate momentum. MS is comparatively vulnerable to multiple compression because wealth-management stability is already capitalized at a premium valuation, while a risk-asset drawdown would pressure both transactional fees and asset-based revenues.

Consensus is likely over-crediting generic AI efficiency claims. In the next 12 months, incremental AI spend may initially lift technology and compensation/restructuring costs faster than it reduces front-office headcount; the material earnings benefit is more plausibly a 2-4 year outcome. Near-term sector upside instead depends on a benign credit backdrop, stable-to-higher equity markets, and conversion of announced M&A into closed transactions. A sharp rate-cut cycle, widening credit spreads, or a decline in equity issuance would expose the operating-leverage trade quickly.

Key Decisions for Investors

• Initiate a 6-12 month long C / short MS pair, sized beta-neutral: C has rerating potential from credible cost and capital-return execution, while MS carries greater downside if wealth-management net flows or equity markets soften. Target 15-20% relative return; exit if C fails to demonstrate sequential expense discipline or guides returns lower.
• Maintain JPM as the core long within U.S. financials over the next 3-6 months, funded against XLF or a diversified bank basket rather than outright sector exposure. It is the preferred hedge against a slowdown in underwriting because non-capital-markets earnings can absorb a weaker deal cycle; reassess if net-interest-income guidance is cut materially following a rapid easing cycle.
• Use GS tactically, not structurally: buy on 5-8% market-driven pullbacks ahead of quarterly results only if M&A completion, equity issuance and trading-volume indicators remain firm. Take profits into evidence that fee-pool growth is decelerating; GS needs continued upside revisions to support its current valuation versus C.
• Avoid adding MS at current relative valuation absent evidence of accelerating net new assets and sustained investment-banking fee gains. A break in equity-market breadth or weaker quarterly asset-management flows is the catalyst to express the short leg of the C/MS pair.